The immunopotentiation of human B lymphocyte stimulator C-terminal peptide

Acta Biochimica et Biophysica Sinica

Volumn 35, Issue 12, 2003, Pages 1128-1132

  Tian, Rui Yang ^a   Han, Wei ^a   Yu, Ying ^a   Chen, Yue ^a   Yu, Gu Song ^a   Yang, Sheng Li ^a   Gong, Yi ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

BCMA; C BLyS; Inclusion body; Renaturation

Indexed keywords

B LYMPHOCYTE STIMULATOR C TERMINAL PEPTIDE; COMPLEMENTARY DNA B LYMPHOCYTE STIMULATOR C TERMINAL PEPTIDE; FC RECEPTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOSTIMULATING AGENT; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA LIBRARY; DRUG PROTEIN BINDING; ESCHERICHIA COLI; FETUS; GENE AMPLIFICATION; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IMMUNOPOTENTIATION; IMMUNOSTIMULATION; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SPLEEN CELL;

ANIMALS; B-CELL ACTIVATING FACTOR; BINDING, COMPETITIVE; CELL DIVISION; CHROMATOGRAPHY, ION EXCHANGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MURAMIDASE; PROTEIN FOLDING; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; ESCHERICHIA COLI;

EID: 1642320398     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D et al. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science, 1999, 285(5425): 260-263
2. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med, 1999, 189(11): 1747-1756
3. Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MacKay F et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med, 2000, 192(1): 129-136
4. Yan M, Marsters SA, Grewal IS, Wang H, Ashkenazi A, Dixit VM. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol, 2000, 1(1): 37-41
5. Marsters SA, Yan M, Pitti RM, Haas PE, Dixit VM, Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr Biol, 2000, 10(13): 785-788
6. Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature, 2000, 404(6781): 995-999
7. Nardelli B, Moore PA, Li Y, Hilbert DM. B lymphocyte stimulator (BLyS): A therapeutic trichotomy for the treatment of B lymphocyte diseases. Leuk Lymphoma, 2002, 43(7): 1367-1373
8. Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science, 2001, 293(5537): 2108-2111
9. Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S, Cancro M et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol, 2001, 11(19): 1547-1552
10. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS et al. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity, 2002, 17(4): 515-524
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratry Manual, 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989
12. Rederick M, Ausubel F, Brent R, Kingston RE, Moor DD, Seidman JG, Smith JA et al. Short Protocols in Molecular Biology, 4th ed. John Wiley & Sons Inc., 1999
13. Liu Y, Xu L, Opalka N, Kappler J, Shu HB, Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell, 2002, 108: 383-394
14. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med, 1999, 190(11): 1697-1710
15. Khare SD, Sarosi I, Xia XZ, McCabe S, Miner K, Solovyev I, Hawkins N et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA, 2000, 97(7): 3370-3375
16. Zhang J, Roschke V, Baker KP, Wang Z, Alarcon GS, Fessler BJ, Bastian H et al. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol, 2001, 166(1): 6-10
17. Cheema GS, Roschke V, Hilbert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum, 2001, 44(6): 1313-1319
18. Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J et al. Association of BAFF/BlyS overexpression and altered B cell differentiation with Sjoxgren's syndrome. J Clin Invest, 2002, 109(1): 59-68